Inspire Medical Systems Inc [INSP] stock prices are down -3.35% to $205.00 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The INSP shares have lost -1.01% over the last week, with a monthly amount glided 4.06%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Inspire Medical Systems Inc [NYSE: INSP] stock has seen the most recent analyst activity on May 08, 2024, when BofA Securities downgraded its rating to a Neutral and also revised its price target to $225 from $265. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on April 19, 2024, and set its price target to $285. On March 19, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $250 on the stock. Jefferies initiated its recommendation with a Buy and recommended $245 as its price target on January 19, 2024. Stifel downgraded its rating to Hold for this stock on January 02, 2024, but kept the price target unchanged to $210. In a note dated December 13, 2023, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $245 to $187.
The stock price of Inspire Medical Systems Inc [INSP] has been fluctuating between $123.00 and $257.40 over the past year. Currently, Wall Street analysts expect the stock to reach $237.8 within the next 12 months. Inspire Medical Systems Inc [NYSE: INSP] shares were valued at $205.00 at the most recent close of the market. An investor can expect a potential return of 16.0% based on the average INSP price forecast.
Analyzing the INSP fundamentals
The Inspire Medical Systems Inc [NYSE:INSP] reported sales of 705.71M for trailing twelve months, representing a surge of 29.65%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is -0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 202.31 points at the first support level, and at 199.61 for the second support level. However, for the 1st resistance point, the stock is sitting at 210.37, and for the 2nd resistance point, it is at 215.73.
Ratios To Look Out For
It’s worth pointing out that Inspire Medical Systems Inc [NYSE:INSP]’s Current Ratio is 9.25. On the other hand, the Quick Ratio is 8.35, and the Cash Ratio is 2.86. Considering the valuation of this stock, the price to sales ratio is 8.66, the price to book ratio is 9.58 and price to earnings (TTM) ratio is 1128.23.
Transactions by insiders
Recent insider trading involved Ebeling Philip, Officer, that happened on Sep 11 ’24 when 5453.0 shares were purchased. Director, McCormick Shawn completed a deal on Sep 09 ’24 to sell 800.0 shares. Meanwhile, Chief Technology Officer Rondoni John sold 31.0 shares on Sep 09 ’24.
